Please check your internet connection and try again.
# Sodium Phosphate Enema
## Overview
Sodium phosphate enemas are hypertonic saline solutions that act as osmotic laxatives by drawing water into the colon, softening stool and stimulating bowel evacuation.
## Primary Indications
Bowel preparation for diagnostic procedures (e.g., sigmoidoscopy, colonoscopy) or surgery.
Relief of occasional constipation.
## Adult Dosing
* **Bowel Preparation:** Typically, one 4.5 fl oz (133 mL) bottle administered as a single dose. Administer slowly to minimize cramping. Do not administer more than one bottle in a 24-hour period.
* **Constipation Relief:** One 2.25 fl oz (67 mL) bottle administered as a single dose. Do not administer more than one bottle in a 24-hour period.
## Pediatric Dosing
* **Ages 2 to under 6 years:** 1/4 of a 4.5 fl oz bottle (approx. 33 mL).
* **Ages 6 to 12 years:** 1/2 of a 4.5 fl oz bottle (approx. 67 mL).
* **Ages 12 years and older:** Adult dose (one 4.5 fl oz bottle for bowel prep, or one 2.25 fl oz bottle for constipation).
*Note: Dosing for children under 2 years is not established and should be used with extreme caution and under medical supervision due to increased risk of electrolyte imbalance.*
## Dose Adjustments
No specific dose adjustments for renal or hepatic impairment are established for enema use; however, caution is warranted in patients with pre-existing renal or cardiac conditions.
## Contraindications
* Congenital or acquired megacolon.
* Intestinal obstruction or perforation.
* Severe heart failure.
* Anuria.
* Children under 2 years of age.
* Patients with impaired renal function or those on medications that may affect renal function (e.g., diuretics, ACE inhibitors, ARBs).
* Patients with electrolyte abnormalities.
* Use with caution in elderly patients.
## Adverse Effects
* **Common:** Abdominal cramping, bloating, nausea, vomiting, rectal irritation.
* **Serious:** Hyperphosphatemia, hypocalcemia, hypokalemia, metabolic acidosis, dehydration, renal damage, cardiac arrhythmias, seizures.
## Key Drug Interactions
* **Diuretics, ACE inhibitors, ARBs:** Concomitant use may increase the risk of dehydration and electrolyte abnormalities, particularly hyperphosphatemia and hypocalcemia, and can worsen renal function.
* **Other laxatives:** May potentiate the effects and increase the risk of dehydration and electrolyte imbalance.
## Monitoring
* Monitor for signs and symptoms of dehydration and electrolyte imbalance (e.g., thirst, dry mouth, dizziness, muscle cramps, weakness, confusion, irregular heartbeat).
* Renal function and electrolytes (phosphate, calcium, potassium) may be considered, especially in patients with risk factors or after repeated use.
## Clinical Pearls
* Instruct patients to retain the enema for the recommended time (typically 5 minutes or as long as possible) for optimal effect.
* Avoid concurrent use of other phosphate-containing products (oral or rectal) to prevent accumulation.
* The risk of severe electrolyte disturbances, including potentially fatal hyperphosphatemia, hypocalcemia, and renal failure, is increased in children, the elderly, and patients with renal impairment or cardiac conditions.
---
*Disclaimer: This information is intended for clinical use and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant literature for complete details.*
